Already contributed? Log in to hide these messages.
“Preventing transmission is the biggest thing that we can do to help keep everybody healthy,” Horn stated.
We are dedicated to delivering the unwavering, fact-based journalism that everyone deserves.
Thank you once more for your past support. We are truly appreciative of readers like you! your initial contributions helped us reach this point and strengthened our newsroom, providing resilience during challenging periods. As we move forward, your assistance is more crucial than ever. We hope you will join us once again.
Already contributed? Log in to hide these messages.
“Preventing transmission is the biggest thing that we can do to help keep everybody healthy,” Horn stated.
Suffering from a sore throat or sniffles? While rapid at-home tests offer convenience, their sensitivity can be lacking. Now, a new biosensing technology promises to increase the accuracy of rapid at-home diagnostics, potentially detecting viruses like COVID-19 with much greater precision.
The innovative test, developed by researchers at the **University of California, Berkeley**, leverages the “coffee-ring effect,” a natural evaporation process where particles concentrate at the edge of a drying droplet. It combines this with plasmonics and artificial intelligence to identify disease biomarkers rapidly.
Kamyar Behrouzi, who recently earned a Ph.D. from **UC Berkeley**, noted, โThis simple yet effective technique can offer highly accurate results in a fraction of the time compared to traditional diagnostic methods.โ
He added that the technology paves the way for more affordable, accessible diagnostics, especially in low-resource settings.”
The technology uses plasmonic nanoparticles, which uniquely interact with light. A user adds a liquid droplet, such as a nasal swab, to a membrane. As the droplet dries, disease biomarkers concentrate. A second droplet, containing nanoparticles engineered to attach to these biomarkers, is added. If biomarkers are present, the nanoparticles form patterns that alter light interaction. These changes can be observed or analyzed via an AI-powered smartphone app.
Results are available in under 12 minutes, with COVID-19 detection being up to 100 times more sensitive than existing tests.
According to the CDC, sepsis affects at least 1.7 million adults in the U.S. annually and contributes to nearly 350,000 deaths. (CDC.gov)
โOne of the key proteins that we are able to detect with this method is a biomarker of sepsis, a life-threatening inflammatory response to a bacterial infection that can develop rapidly in people over 50. Every hour is critical, but culturing bacteria to determine the source of the infection can take a few days. Our technique could help doctors detect sepsis in 10 to 15 minutes.”
โLiwei Lin, Study Senior Author, Distinguished Professor of Mechanical Engineering at UC Berkeley
The research team has already produced a prototype of a home testing kit that is similar to current at-home COVID tests.
Lin hopes that our technology makes it easier and more accessible for people to regularly screen for conditions like prostate cancer without leaving the home.”
Additional co-authors of the study include **Zahra Khodabakhshi Fard**, **Chun-Ming Chen**, **Peisheng He** and **Megan Teng** of **UC Berkeley**.
“`html
Table of Contents
Medan, north Sumatra is experiencing a measles outbreak, with the Health Office (DHO) reporting a meaningful increase in cases. From January to May 2025, the city recorded 127 measles cases, a notable rise compared to the 104 cases reported in all of 2024. Health officials attribute the outbreak to low immunization coverage, particularly among elementary school children.
The Medan City health Office,through the Head of Disease Prevention and Control Division (P2P),Pocut Fatimah Fitri,confirmed the increase in measles cases. The surge has prompted increased vigilance and strategic interventions to control the spread of the highly contagious viral disease.
Did You Know? Measles cases are rising globally. The European Region reported over 127,000 cases in 2024, the highest number in over 25 years [1].
Measles, caused by the Morbillivirus virus, is characterized by fever, sore throat, and a distinctive rash across the body. The infection begins in the respiratory tract and spreads through airborne saliva droplets. “This virus can be transmitted easily through droplets or splash of saliva from the mouth and nose of measles patients, which comes out when coughing, sneezing, or talking,” explained Pocut Fatimah Fitri.
According to Pocut, a primary factor contributing to the measles outbreak is the lack of sufficient immunization coverage, especially among elementary school children.low participation in the School Child Immunization Month Program (BIAS) has exacerbated the situation.
Pro Tip: Maintaining high vaccination rates is crucial to achieving herd immunity and protecting vulnerable populations from measles.
Measles is preventable through the measles-rubella (MR) vaccine. The Medan Health Office is intensifying the implementation of the BIAS program in elementary schools and Madrasah ibtidaiyah as a sustainable prevention strategy. The BIAS program is conducted twice annually, from August to November, providing measles immunization to first-grade students (
As COVID-19 continues to circulate, a concerning symptom known as “razor blade throat” has emerged, causing alarm. People are experiencing severe sore throats, prompting questions about its prevalence and severity. Hereโs a breakdown of what you need to know.
Infections with COVID can produce a variety of unpleasant symptoms, including fever, fatigue, and congestion. Reports from China mention the sensation of a “razor blade throat” among some patients. This symptom has spurred online searches in the United States, with people looking for information on “new covid variant painful symptom” and “covid razor throat.”
According to Dr. William Schaffner, a professor at Vanderbilt University Medical Center, the emergence of distinctive symptoms often accompanies new variants. However, these symptoms have appeared before. Dr. Carrie Horn, the chief medical officer at National Jewish Health, notes that a severe sore throat is not unique to current variants.
โIn the past, as new variants have come on the scene, there almost invariably have been questions about distinctive symptoms, and after a while, when you gather a lot of data, turns out not to be the case โ all of these symptoms have occurred before.โ
โDr. William Schaffner, Professor
Dr. Mark Burns, an infectious disease expert, points out that sore throats, along with fever and fatigue, are all potential symptoms of COVID. The Centers for Disease Control and Prevention (CDC) recommends that those at higher risk should receive two COVID vaccinations annually. This includes the elderly, people with underlying health conditions, and pregnant individuals.
Recent data from the CDC indicates that vaccination has been effective in preventing severe illness and hospitalization. Wearing masks indoors, social distancing, and handwashing also offer protection against the virus.
If you experience any COVID symptoms like a sore throat, it is essential to get tested. Seek medical advice, especially if you’re in a high-risk group. Over-the-counter medications, such as alternating ibuprofen and Tylenol, can help manage symptoms. Additionally, staying hydrated is crucial. Preventing the spread of germs is vital, including staying home when sick and wearing a mask if you cannot.
Table of Contents
As summer progresses, new COVID-19 variants continue to emerge and circulate worldwide. The LP.8.1 variant remains the predominant strain,but health organizations are closely monitoring the spread of NB.1.8.1 (dubbed “Nimbus”) and XFG (“Stratus”).The World Health Organization (WHO) is tracking these developments to assess their potential impact on public health and vaccine effectiveness.
Recent data indicates that COVID-19 remains a concern, even as it receives less media attention. Between June 19 and June 25, health authorities reported 305 new infections and 2 deaths. While the LP.8.1 variant is currently dominant, the prevalence of the Nimbus variant is increasing, and the WHO is closely monitoring Stratus, a recombinant of LF.7 and LP.8.1.2, due to its rapid global growth WHO.
Did You Know? The elderly, particularly those over 80, are still the most vulnerable to severe outcomes from COVID-19, including hospitalization and death.
Despite the ongoing evolution of the virus, experts emphasize that seasonality is not the primary driver of transmission. instead, the emergence of new variants and their subsequent spread are the key factors influencing infection rates. Typically, it takes about six months for a new variant to reach its peak diffusion, according to infectious disease specialists CDC.
| Metric | Value |
|---|---|
| New Infections | 305 |
| Deaths | 2 |
| Dominant Variant | LP.8.1 |
| Variants of Interest | Nimbus, Stratus |
While the Stratus variant has mutations that may enhance its ability to evade antibodies, current evidence suggests it does not pose a substantially greater threat than other circulating strains.interestingly, in India, where Stratus is prevalent, the Nimbus variant has not spread as widely.
Reports from India suggest that a frequent symptom among COVID-19 patients is a hoarse voice, accompanied by dry cough, irritation, and sore throat. Similarly, in the United Kingdom, where Nimbus is circulating, a severe sore throat with acute pain when swallowing is a notable symptom. other common symptoms include fatigue, cough, fever, muscle pain, and nasal congestion.
Pro Tip: Stay informed about the specific symptoms associated with emerging variants in your region to better identify potential infections and seek timely medical advice.
The WHO has stated that currently approved COVID-19 vaccines are expected to remain effective in protecting against symptomatic and severe disease caused by variants like Stratus. ongoing research and surveillance are crucial to continuously assess vaccine effectiveness and adapt public health strategies as needed.
The ongoing evolution of SARS-CoV-2, the virus that causes COVID-19, is characterized by the emergence of new variants. these variants arise due to mutations in the virusS genetic material, which can affect its transmissibility, severity, and ability to evade immune responses. Public health organizations worldwide closely monitor these variants to assess their potential impact and inform appropriate interventions.
Understanding the dynamics of variant emergence and spread is crucial for developing effective strategies to mitigate the pandemic. Factors such as vaccination rates, public health measures, and global travel patterns all play a role in shaping the trajectory of diffrent variants. Continuous research and collaboration are essential to stay ahead of the virus and protect public health.
Continue practicing good hygiene, including frequent handwashing, wearing a mask in crowded indoor settings, and maintaining physical distance. stay up-to-date with your vaccinations and booster shots, as recommended by health authorities.
Refer to official sources such as the world Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and your local health department for the most accurate and up-to-date information.
The rate at which new variants emerge can vary. SARS-CoV-2 is an RNA virus, which tends to mutate more frequently than DNA viruses. Ongoing surveillance and research are essential to track the emergence and spread of new variants.
Currently, most treatments for COVID-19 are effective against a range of variants. Though, some variants may exhibit reduced susceptibility to certain monoclonal antibody treatments. Consult with your healthcare provider for personalized treatment recommendations.
Scientists use genomic sequencing to identify and characterize new variants. They analyze the virus’s genetic code to identify mutations and assess their potential impact on its properties. Variants are then classified based on their characteristics and potential risks.
Disclaimer: This article provides general information and should not be considered medical advice. Consult with a healthcare professional for personalized guidance.
Stay informed and take necessary precautions to protect yourself and your community from COVID-19. What are your thoughts on the latest COVID-19 variant developments? How has COVID-19 impacted your daily life?
A fresh wave of COVID-19 cases is hitting India, as a new variant, nicknamed โNimbusโ, gains global attention. This strain is causing an unusual symptom: an intensely painful sore throat, prompting public health officials to monitor its spread closely.
The NB.1.8.1 variant, also known as โNimbus,โ has quickly circulated, spreading through China and Hong Kong. According to reports, cases have been documented in several US states including California, Washington, Virginia, and New York. Australia has also reported cases, and the UK recorded 13 instances in June, accompanied by a rise in hospitalizations.
The main reported symptom of the Nimbus variant is a severely painful sore throat, also associated with fever, chills, cough, shortness of breath, and loss of taste or smell. The World Health Organization (WHO) indicates that, while it’s spreading, it doesn’t seem to cause more severe illness than earlier strains and is currently considered low risk.
โThe WHO assesses the additional risk to the global public as currently low, and existing COVID-19 vaccines are considered effective in preventing severe disease,โ
โDr. Naveed Asif, General Practitioner
By mid-May, NB.1.8.1 accounted for nearly 11% of all sequenced COVID samples worldwide, which signals an increased circulation. The Centers for Disease Control and Prevention (CDC) reported that COVID-19-related hospitalizations rose 10% nationwide during the week ending July 13, 2024 (CDC).
Vaccines approved by the US FDA, including Moderna, Pfizer-BioNTech, and Novavax, are expected to offer protection against NB.1.8.1, especially since it’s part of the Omicron JN.1 lineage. People with health issues, such as diabetes, heart disease, or hypertension, should take extra precautions due to potentially weaker immune responses.
Scientists believe NB.1.8.1 spreads quickly due to its stronger binding with human cells. Dr. Chun Tang suggested slight changes to its spike protein might make it more transmissible or help it evade immunity.
Prevention measures remain consistent: Masking up in crowded spots, covering the mouth during coughs or sneezes, regular handwashing, and avoiding public spaces when unwell. Ventilated areas are safer, especially during transmission spikes.